KRISTEN CRUMPTON: Open Payments
NPI 1578180493 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,361 in 107 payments from 18 companies in 2025. Trend: 2023 $1,798 · 2024 $2,415 · 2025 $2,361
Food & beverage: $2,296Education: $65
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 13 | $473 |
| ABBVIE INC. | 30 | $422 |
| Janssen Biotech, Inc. | 11 | $273 |
| PFIZER INC. | 16 | $212 |
| Galderma Laboratories, L.P. | 10 | $141 |
| Botanix SB Inc | 2 | $124 |
| Lilly USA, LLC | 2 | $121 |
| GENZYME CORPORATION | 3 | $119 |
| Verrica Pharmaceuticals Inc. | 1 | $118 |
| Novartis Pharmaceuticals Corporation | 5 | $96 |
Products named: Bimzelx, TREMFYA, SKYRIZI, RINVOQ, DUPIXENT, SOFDRA, EBGLYSS, YCANTH.
Industry payments across FL — which companies pay providers there.
